Yes, Cimzia (certolizumab pegol) is a biologic DMARD used to treat moderately to severely active rheumatoid arthritis. It works by blocking a chemical messenger called TNF-alpha, which plays a role in the immune system's inflammatory attacks on joints.
It's given as a subcutaneous (under the skin) injection every two to four Show Full Answer
Yes, Cimzia (certolizumab pegol) is a biologic DMARD used to treat moderately to severely active rheumatoid arthritis. It works by blocking a chemical messenger called TNF-alpha, which plays a role in the immune system's inflammatory attacks on joints.
It's given as a subcutaneous (under the skin) injection every two to four weeks using a prefilled syringe. Some common side effects to be aware of include:
- Upper respiratory tract infections
- Urinary tract infections
- Rash at the injection site
There are also some rare but serious side effects to discuss with your doctor, including:
- Severe infections
- Increased risk for certain cancers
- Heart failure
- Severe allergic reactions
- Nerve damage
- Low blood cell counts
Many myRAteam members have shared positive experiences with Cimzia. One myRAteam member said, "I'm feeling a lot better after my Cimzia shot."
As always, it's best to talk with your rheumatologist about whether Cimzia is the right fit for you and to report any side effects you experience.
2 days ago
Join
Your Privacy Choices
